First Ethicon Physiomesh lawsuit to head to trial scheduled for 2018

Feb. 16, 2017 – San Diego, CA — Johnson & Johnson’s Ethicon Inc. will defend itself in the first Physiomesh lawsuit to go to trial next year. The trial is scheduled...

Hernia Mesh Complications: How to Submit Adverse Event Reports and Why You Should

Feb. 15, 2017 – San Diego, CA — Hernia mesh complications can occur long after the initial hernia repair surgery. This point was highlighted in a recent study, which found...

Government report on power morcellators highlights failures of FDA adverse event reporting

Feb. 14, 2017 – San Diego, CA — A new report from the Government Accountability Office (GAO) delves deep into the risks posed by power morcellators and exposes gaps within the...

DuPont agrees to $671 million settlement with plaintiffs injured by cancer-causing Teflon chemical

Feb. 13, 2017 – San Diego, CA — DuPont has agreed to pay more than $670 million in cash to settle thousands of lawsuits accusing the company of poisoning local water...

Xarelto maker stops latest trial early citing positive results

Feb. 10, 2017 – San Diego, CA — The results of the newest Xarelto clinical trial were so promising, Janssen Research & Development decided to end the trial early. Janssen is...

Elderly patients better off taking placebo in new Risperdal study

Feb. 9, 2017 – San Diego, CA — For elderly patients in palliative care, treating symptoms of delirium with the antipsychotic Risperdal may make some symptoms worse, a new study finds....

FDA speeds up recall process – now posts on website as soon as recall occurs

Feb. 8, 2017 -- San Diego, CA — U.S. consumers will now know when a medical device is recalled sooner than they had in the past. The U.S. Food and Drug...

What do lemons have to say about breast cancer? Apparently, a lot!

Feb. 7, 2017 -- San Diego, CA — The nonprofit group Worldwide Breast Cancer is using an unlikely source to make it easier for women to detect early breast cancer: lemons. It's all...

Farxiga plaintiffs denied ‘class-wide’ consolidation with Invokana request new MDL

Feb. 6, 2017 – San Diego, CA — People injured by the type II diabetes medication Farxiga may see their cases consolidated after all. One man suing AstraZeneca – the maker...

Will J&J try to settle the next Risperdal lawsuit before it heads to trial? [UPDATE]

[UPDATE] Feb. 22, 2017 — Johnson & Johnson settled the case one week before it went to trial. Read the story on our blog: J&J continues settlement trend, resolves another Risperdal lawsuit one...